Home   HELP  /   AYUDA  /   求助 : help-desk@bctrials.org  /   (415) 476-5777 Click to print page  Print

Browse Trials

In response to COVID-19, some breast cancer trials have temporarily stopped enrolling new patients. Use the contact information in our trial listings to call or email the research site for information about a trial's status.

Visit COVID-19 & Cancer Clinical Trials on Metastatic Trial Talk for regularly updated information about clinical trials during the coronavirus pandemic.

Currently viewing trials
(Last updated: July 07, 2020)

Zip Code:

Narrow my choices:

Radius (miles): All U.S.

20 All U.S.
Early stage    Advanced 
Treatment    Non-treatment 
Phase    I     II     III 
Display Only New Trials 



Hormone Therapy

Radiation Oncology


Surgery: Reconstruction

Targeted Therapy: All

Targeted Therapy: Anti-HER2 Therapy

Targeted Therapy: CDK Inhibitors

Targeted Therapy: PARP Inhibitors

Targeted Therapy: Tumor Mutations

Targeted Therapy: Other Targeted Therapy

Vaccines and Immunotherapy

Other Treatment



Complementary and Alternative Medicine

Decision Support

Diagnosing Breast Cancer

Genetics/Family History

Having Children


Managing Side Effects

No Travel Required

Predicting Response to Treatment

Preventing Breast Cancer

Preventing Recurrence





NEAREST SITE: 2376 miles
University of Virginia

VISITS: Number of visits unavailable


NCT ID: NCT04116320

FUSA Alone or With Immunotherapy in Advanced Breast Cancer

Pilot Evaluation of Focused Ultrasound Ablation and Focused Ultrasound Ablation Plus PD-1 Antibody Blockade in Advanced Solid Tumors Scientific Title

To compare the safety and effects (good or bad) of Focused Ultrasound Ablation (FUSA) when it is used alone, with a PD-1 inhibitor, with imiquimod (Aldara®), or with both a PD-1 inhibitor and imiquimod (Aldara®).
Who is this for?
People with advanced (some stage III) or metastatic (stage IV) breast cancer who have no standard treatment options available.    Full eligibility criteria
Contact research site

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will be assigned to 1 of 4 groups depending on your diagnosis: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Focused Ultrasound Ablation (FUSA), once</li> <li class="seamTextUnorderedListItem">PD-1 inhibitor therapy, by IV, every 3 weeks, ongoing</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Focused Ultrasound Ablation (FUSA), once</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Focused Ultrasound Ablation (FUSA), once</li> <li class="seamTextUnorderedListItem">PD-1 inhibitor therapy, by IV, every 3 weeks, ongoing</li> <li class="seamTextUnorderedListItem">Imiquimod (Aldara®), cream applied to skin</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 4</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Focused Ultrasound Ablation (FUSA), once</li> <li class="seamTextUnorderedListItem">Imiquimod (Aldara®), cream applied to skin</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">FUSA (Focused Ultrasound Ablation) uses ultrasound waves to kill cancer cells. It may also trigger your immune system to go after cancer cells. </li> <li class="seamTextUnorderedListItem">PD-1 inhibitors are a type of immunotherapy called a checkpoint inhibitor. They stimulate the body's immune system to fight cancer cells. </li> <li class="seamTextUnorderedListItem">Imiquimod (Aldara®) is a cream-based immunotherapy. It is used to treat skin cancer and other types of skin disorders. Its use in breast cancer is considered experimental. </li> <li class="seamTextUnorderedListItem">This study is also enrolling patients with other types of advanced cancers.</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04116320' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://fusfoundation.org/diseases-and-conditions/oncological/breast-cancer' target='_blank'>Focused Ultrasound Foundation: Breast Cancer</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.researchgate.net/figure/Ultrasound-guided-focused-ultrasound-ablation-device-Echopulse-Theraclion-VTU_fig1_268788751' target='_blank'>ResearchGate: Echopulse</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod' target='_blank'>NCI Drug Dictionary: Imiquimod</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/immunotherapy' target='_blank'>Breastcancer.org: Immunotherapy</a> </li><li class='seamTextUnorderedListItem'><a href='https://oncologypro.esmo.org/Oncology-News/OncologyNews-archives-2017/Topical-Imiquimod-Regimen-Shows-Promise-For-Chest-Wall-Cutaneous-Breast-Cancer-Metastases' target='_blank'>ESMO: Topical Imiquimod Regimen Shows Promise For Chest Wall, Cutaneous Breast Cancer Metastases</a> </li></ul>
See more